<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    MedAnswers

    MedAnswers

    With 40 million infertile people worldwide, MedAnswers connects patients with mult...

    With 40 million infertile people worldwide, Med...

    Amount Raised:    $145,702.50
    Fundraising Status:    EC
    Filing Type:    CF
    Sensus Healthcare, Inc.

    Sensus Healthcare, Inc.

    Sensus Healthcare, Inc. (NASDAQ: SRTS; SRTSW) is a medical device company that is ...

    Sensus Healthcare, Inc. (NASDAQ: SRTS; SRTSW) i...

    Filing Type:    PU
    Oncternal Therapeutics, Inc.

    Oncternal Therapeutics, Inc.

    Oncternal Therapeutics is a clinical-stage oncology company developing a diverse p...

    Oncternal Therapeutics is a clinical-stage onco...

    Filing Type:    PU
    Atossa Genetics Inc.

    Atossa Genetics Inc.

    Seattle-based Atossa Genetics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical...

    Seattle-based Atossa Genetics (NASDAQ: ATOS) is...

    Filing Type:    PU
    Clearside Biomedical, Inc.

    Clearside Biomedical, Inc.

    Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to developing ...

    Clearside Biomedical, Inc. is a biopharmaceutic...

    Filing Type:    PU
    Insmed, Inc.

    Insmed, Inc.

    At Insmed we are on a mission to transform the lives of patients battling serious ...

    At Insmed we are on a mission to transform the ...

    Filing Type:    PU
    Odonate Therapeutics, Inc.

    Odonate Therapeutics, Inc.

    We are a pharmaceutical company dedicated to the development of best-in-class ther...

    We are a pharmaceutical company dedicated to th...

    Filing Type:    PU
    Cue Biopharma, Inc.

    Cue Biopharma, Inc.

    Cue Biopharma is an innovative clinical stage immunotherapy company developing a n...

    Cue Biopharma is an innovative clinical stage i...

    Filing Type:    PU
    Advaxis, Inc.

    Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of ca...

    Advaxis was founded on the vision that no one s...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.